iAngels

iAngels is a Tel Aviv-based women-led venture and angel investment platform that lets global investors co-invest alongside top-tier Israeli angels in heavily vetted deals, with checks of $250K to $1M at seed through Series B. The firm has built itself around an aggregation model that gives international investors structured access to Israeli venture deals while giving founders access to a deep network of operating angels and follow-on investors. Founders pitching iAngels are talking to a platform that has been active in Israeli venture for over a decade.

The thesis covers digital health and AI and machine learning in healthcare. iAngels is interested in companies with strong technical or clinical foundations, credible founders, and clear paths to international commercialization. The healthcare exposure sits alongside broader investments in technology and consumer sectors, and the firm tends to favor companies that have been validated by experienced Israeli operators before they reach the platform’s investor network. The vetting process is part of the value proposition for both founders and co-investors and is reflected in the diligence depth founders should expect.

Check sizes of $250K to $1M place iAngels as a participating co-investor across seed, Series A, and Series B rounds, frequently alongside Israeli and international institutional VCs. The geographic focus is Israel, with portfolio companies generally building toward global markets. Founders should expect a longer diligence process than a typical VC reflecting the platform’s investor approval model, and they should treat the relationship as bringing both a check and a network of co-investors and angels rather than a single capital source.

The team includes investors and platform operators with backgrounds spanning Israeli venture, finance, and operating roles, and the firm has cultivated a network of high-profile Israeli angels who participate in deals alongside the platform’s broader investor base. That bench gives portfolio companies access to advisors and follow-on investors who can support fundraising and commercial expansion across Israeli, US, and European markets.

iAngels’ working style is collaborative and network-oriented. The firm typically takes observer or board roles depending on the deal and engages on follow-on fundraising, commercial strategy, and connections to Israeli operating angels who can advise portfolio companies. iAngels co-invests with Israeli and international healthcare-focused funds, family offices, and corporate strategics, and has supported portfolio companies through subsequent rounds and exits. Founders building Israeli digital health or AI in healthcare companies who want access to a vetted network of Israeli angels and a platform of international co-investors will find iAngels a useful addition to a round. Founders looking for a single primary check or a heavy operating partner will need to anchor the round elsewhere and treat iAngels as a complementary participant.